We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
-2.7%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$228M
AUM Growth
-$18.3M
Cap. Flow
-$9.44M
Cap. Flow %
-4.13%
Top 10 Hldgs %
58.67%
Holding
92
New
19
Increased
15
Reduced
21
Closed
24

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$2.65M
2
PYPL icon
PayPal
PYPL
+$1.2M
3
TSM icon
TSMC
TSM
+$1.05M
4
IBB icon
iShares Biotechnology ETF
IBB
+$912K
5
GLD icon
SPDR Gold Trust
GLD
+$877K

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$6.26M
2
AMGN icon
Amgen
AMGN
+$2.87M
3
VZ icon
Verizon
VZ
+$2.6M
4
BMY icon
Bristol-Myers Squibb
BMY
+$2.03M
5
INCY icon
Incyte
INCY
+$1.78M

Sector Composition

Rank Sector Weight
1 Healthcare 34.68%
2 Technology 11.59%
3 Communication Services 7.6%
4 Financials 4.91%
5 Consumer Discretionary 2.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$453B
$37.7M 16.51%
104,000
+69,000
+197% +$24.5M
ITCI
2
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$14.6M 6.39%
238,500
-120,500
-34% -$6.26M
ABBV icon
3
AbbVie
ABBV
$443B
$14.4M 6.3%
88,750
-10,568
-11% -$1.54M
MU icon
4
Micron Technology
MU
$930B
$13M 5.71%
167,500
-10,000
-6% -$853K
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.36T
$12.2M 5.32%
87,000
– –
SPY icon
6
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$11.1M 4.85%
+24,500
New +$10.9M
REGN icon
7
Regeneron Pharmaceuticals
REGN
$78.5B
$10.3M 4.5%
14,700
-2,500
-15% -$1.58M
ARGX icon
8
argenx
ARGX
$53.4B
$7.88M 3.45%
25,000
– –
XNCR icon
9
Xencor
XNCR
$1.5B
$6.86M 3%
257,000
+15,237
+6% +$491K
BAC icon
10
Bank of America
BAC
$435B
$6M 2.63%
145,500
– –
GLD icon
11
SPDR Gold Trust
GLD
$131B
$5.42M 2.37%
30,000
+5,000
+20% +$877K
SPY icon
12
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$4.52M 1.98%
+10,000
New +$4.45M
GDX icon
13
VanEck Gold Miners ETF
GDX
$22.7B
$3.93M 1.72%
102,500
-12,500
-11% -$425K
C icon
14
Citigroup
C
$222B
$3.74M 1.64%
70,000
+2,000
+3% +$124K
IAU icon
15
iShares Gold Trust
IAU
$62.9B
$3.68M 1.61%
100,000
– –
INCY icon
16
Incyte
INCY
$24.2B
$3.61M 1.58%
45,500
-24,500
-35% -$1.78M
TPB icon
17
Turning Point Brands
TPB
$1.45B
$3.53M 1.54%
103,676
-8,250
-7% -$280K
GM icon
18
General Motors
GM
$80.4B
$3.5M 1.53%
80,000
-5,000
-6% -$250K
AMD icon
19
Advanced Micro Devices
AMD
$776B
$3.28M 1.44%
30,000
– –
ORCL icon
20
Oracle
ORCL
$374B
$3.23M 1.41%
39,000
-3,500
-8% -$283K
ALNY icon
21
Alnylam Pharmaceuticals
ALNY
$27.5B
$3.1M 1.36%
19,000
+1,000
+6% +$152K
LLY icon
22
Eli Lilly
LLY
$1.02T
$2.96M 1.3%
10,350
-900
-8% -$232K
PRTA icon
23
Prothena Corp
PRTA
$425M
$2.78M 1.22%
76,000
+16,000
+27% +$577K
GDXJ icon
24
VanEck Junior Gold Miners ETF
GDXJ
$6.89B
$2.58M 1.13%
55,000
– –
AOD
25
abrdn Total Dynamic Dividend Fund
AOD
$1.11B
$2.47M 1.08%
257,000
-2,000
-0.8% -$19.4K
1
2 3 4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, DCF Advisers held 92 positions worth $228M, down 7.4% from $247M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

DCF Advisers withdrew a net $9.44M in Q1 2022, closing 24 positions and reducing 21 holdings. Its most notable exit was Amgen, an estimated $2.87M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in Meta Platforms (Facebook) worth $2.36M.

  • DCF Advisers's largest Q1 2022 buy was Meta Platforms (Facebook): 10,600 shares worth $2.36M.
  • DCF Advisers added most to SPDR Gold Trust in Q1 2022, an estimated $877K increase.
  • DCF Advisers's biggest Q1 2022 reduction was Intra-Cellular Therapies Inc., cutting an estimated $6.26M.
  • DCF Advisers fully exited Amgen in Q1 2022, selling an estimated $2.87M.
  • DCF Advisers's ten largest holdings make up 59% of its $228M portfolio in Q1 2022.
  • DCF Advisers opened 19 new positions and closed 24 in Q1 2022.
  • DCF Advisers's portfolio value fell 7.4% quarter-over-quarter to $228M.

Based on DCF Advisers's 13F filing for Q1 2022, filed 13 May 2022.